SEAL BEACH, Calif.,
July 2, 2014 /PRNewswire-iReach/ --
(OTC BB: IDNG)– Independence Energy Corp. ("Independence")
announced today that its Thermofinder FS-700 Pro and FS-700 (retail
version) non-contact infrared thermometer has received U.S. Food
and Drug Administration ("FDA") clearance and is launching
immediately its distribution in the
United States. The FS-700 is currently being sold in Asian
and European markets for both professional and retail markets.
Independence has the exclusive distribution rights in North,
Central and South America.
"We believe the FS-700 is superior to similar devices currently
available in the market," said Howard
Taylor, Independence Chairman and Chief Executive Officer.
"The Thermofinder's exceptional accuracy coupled with consistent
reliability and intelligent design, make it easy to use and
understand. We believe these attributes will translate into mass
market appeal," continued Taylor. Benefits of the FS-700 also
include no cross contamination, ergonomic (one handed) operation,
left or right hand use, attractive pricing, easier to use than oral
or ear thermometers, built in memory and operates silently. The
FS-700 is the first of several medical devices Independence expects
to launch.
The Company is currently in production and awaiting delivery of
units following the successful fulfillment and deployment of the
sales team and has already begun the placement of additional units
to satisfy follow-up orders.
The Company's manufacturing partners produce a broad range of
high quality medical device products for use in the professional
and home environment. The thermometry products as well the other
products are FDA cleared and carry the CE certification with many
other worldwide licenses.
The sales team is a proven group of medical device and supply
professionals; with specific successful history in the professional
and retail sales of next generation thermometry products.
To reflect the major progress achieved and as a next step in the
continuance of the business plan of Independence, the Company also
announces that it intends to change its name to Independence Health
Corp., with the change taking effect as soon as all the filings
necessary are approved.
Independence was incorporated in the State of Nevada. At its inception,
Independence was an exploration stage company engaged in the
acquisition, exploration and development of natural resource
properties. Independence has initiated a program to divest its
investments in oil and gas properties and direct its business
efforts into the medical market. On March
31, 2014, Independence entered into an agreement to acquire
the exclusive all of the assets of American Medical Distributors,
LLC. Pursuant to the agreement, Independence has been granted the
exclusive right to distribute in the Americas certain professional
and consumer grade non-contact infrared thermometers known as the
Thermofinder-700 Pro and FS-700 (retail version), including any and
all future versions.
This release may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Statements contained in this release that are not historical
facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain.
Actual performance and results may differ materially from that
projected or suggested herein due to certain risks and
uncertainties including, without limitation, ability to obtain
financing and regulatory and shareholder approvals for anticipated
actions.
Media Contact: Julie
Calzone, Calzone & Associates, Inc., (337) 235-2924
ext.18, jcalzone@calzone.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Independence Energy Corp.